209 related articles for article (PubMed ID: 25315187)
1. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
6. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
7. Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer.
Song Y; Zhong L; Zhou J; Lu M; Xing T; Ma L; Shen J
Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28975715
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
Atrih A; Mudaliar MA; Zakikhani P; Lamont DJ; Huang JT; Bray SE; Barton G; Fleming S; Nabi G
Br J Cancer; 2014 Mar; 110(6):1622-33. PubMed ID: 24548857
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
10. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
[TBL] [Abstract][Full Text] [Related]
12. HADHA overexpression disrupts lipid metabolism and inhibits tumor growth in clear cell renal cell carcinoma.
Liu S; Liu X; Wu F; Zhang X; Zhang H; Gao D; Bi D; Qu H; Ge J; Xu Y; Zhao Z
Exp Cell Res; 2019 Nov; 384(1):111558. PubMed ID: 31472118
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
[TBL] [Abstract][Full Text] [Related]
14. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
17. Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.
Neely BA; Wilkins CE; Marlow LA; Malyarenko D; Kim Y; Ignatchenko A; Sasinowska H; Sasinowski M; Nyalwidhe JO; Kislinger T; Copland JA; Drake RR
PLoS One; 2016; 11(4):e0154074. PubMed ID: 27128972
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
[TBL] [Abstract][Full Text] [Related]
19. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
[TBL] [Abstract][Full Text] [Related]
20. Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomics.
Dong J; He J; Zhang Z; Zhang W; Li Y; Li D; Xie H; Zuo W; Tang J; Zeng Z; Cai W; Lai L; Yun M; Shen L; Yin L; Tang D; Dai Y
J Proteomics; 2022 Jun; 262():104598. PubMed ID: 35489685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
